Patient Selection and Outcome of Hepatectomy for Noncolorectal Non-Neuroendocrine Liver Metastases

Surgical Oncology Clinics of North America

Volumn 16, Issue 3, 2007, Pages 557-577

  Choi, Eugene A ^a   Abdalla, Eddie K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; VACCINE;

ADRENAL CANCER; ANUS CANCER; ARTIFICIAL EMBOLISM; BILE DUCT CANCER; BREAST CANCER; CANCER STAGING; COLORECTAL CANCER; ESOPHAGUS CARCINOMA; GALLBLADDER CANCER; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMAGING SYSTEM; LIVER METASTASIS; LIVER RESECTION; MELANOMA; OVARY CANCER; PANCREAS TUMOR; PATIENT SELECTION; PROGNOSIS; REVIEW; SMALL INTESTINE CANCER; SOFT TISSUE SARCOMA; SQUAMOUS CELL CARCINOMA; TESTIS CANCER; TREATMENT OUTCOME; UROGENITAL TRACT CANCER; UTERUS CANCER;

HEPATECTOMY; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 34250871851     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.04.005     Document Type: Review

References (57)

1. Choi J. Imaging of hepatic metastases. Cancer Control 1 (2006) 6-12
2. Abdalla E.K., Adam R., Bilchik A.J., et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 10 (2006) 1271-1280
3. Charnsangavej C., Clary B., Fong Y., et al. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 10 (2006) 1261-1268
4. Curley S.A., Marra P., Beaty K., et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 4 (2004) 450-458
5. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 6 (2004) 818-825
6. Aloia T.A., Vauthey J.N., Loyer E.M., et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141 5 (2006) 460-466 [discussion: 466-7]
7. Amersi F.F., McElrath-Garza A., Ahmad A., et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 6 (2006) 581-587
8. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 8 (2005) 1590-1602
9. Maluccio M.A., Covey A.M., Schubert J., et al. Treatment of metastatic sarcoma to the liver with bland embolization. Cancer 7 (2006) 1617-1623
10. Kobayashi K., Gupta S., Trent J.C., et al. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer 12 (2006) 2833-2841
11. Vogl T., Eichler K., Zangos S., et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 3 (2007) 177-184
12. Patel K., Sullivan K., Berd D., et al. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 4 (2005) 297-304
13. Elias D., Cavalcanti de Albuquerque A., Eggenspieler P., et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 5 (1998) 487-493
14. Yamamoto T., Tachibana M., Kinugasa S., et al. Esophagectomy and hepatic arterial chemotherapy following hepatic resection for esophageal cancer with liver metastasis. J Gastroenterol 8 (2001) 560-563
15. Zacherl J., Zacherl M., Scheuba C., et al. Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 5 (2002) 682-689
16. Ochiai T., Sasako M., Mizuno S., et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 8 (1994) 1175-1178
17. Okano K., Maeba T., Ishimura K., et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 1 (2002) 86-91
18. Sakamoto Y., Ohyama S., Yamamoto J., et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 5 (2003) 507-511
19. Ambiru S., Miyazaki M., Ito H., et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg 3 (2001) 279-283
20. Dabaja B.S., Suki D., Pro B., et al. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 3 (2004) 518-526
21. Adam R., Chiche L., Aloia T., et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 4 (2006) 524-535
22. Weitz J., Blumgart L.H., Fong Y., et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 2 (2005) 269-276
23. Lindell G., Ohlsson B., Saarela A., et al. Liver resection of noncolorectal secondaries. J Surg Oncol 2 (1998) 66-70
24. Hemming A.W., Sielaff T.D., Gallinger S., et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 1 (2000) 97-101
25. Harrison L.E., Brennan M.F., Newman E., et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 6 (1997) 625-632
26. Ishikawa T., Horimi T., Shima Y., et al. Evaluation of aggressive surgical treatment for advanced carcinoma of the gallbladder. J Hepatobiliary Pancreat Surg 3 (2003) 233-238
27. Takada T., Yasuda H., Amano H., et al. Simultaneous hepatic resection with pancreato-duodenectomy for metastatic pancreatic head carcinoma: does it improve survival?. Hepatogastroenterology 14 (1997) 567-573
28. Yedibela S., Gohl J., Graz V., et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 10 (2005) 778-785
29. Elias D., Maisonnette F., Druet-Cabanac M., et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2 (2003) 158-164
30. Selzner M., Morse M.A., Vredenburgh J.J., et al. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 4 (2000) 383-389
31. Vlastos G., Smith D.L., Singletary S.E., et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 9 (2004) 869-874
32. Adam R., Aloia T., Krissat J., et al. Is liver resection justified for patients with hepatic metastases from breast cancer?. Ann Surg 6 (2006) 897-907
33. Livraghi T., Goldberg S.N., Solbiati L., et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 1 (2001) 145-149
34. Loberg R.D., Fridman Y., Pienta B.A., et al. Detection and isolation of circulating tumor cells in urologic cancers: a review. Neoplasia 4 (2004) 302-309
35. Alseidi A., Helton W.S., and Espat N.J. Does the literature support an indication for hepatic metastasectomy other than for colorectal primary?. J Gastrointest Surg 1 (2006) 99-104
36. Kierney P.C., van Heerden J.A., Segura J.W., et al. Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review. Ann Surg Oncol 4 (1994) 345-352
37. Schwartz S.I. Hepatic resection for noncolorectal nonneuroendocrine metastases. World J Surg 1 (1995) 72-75
38. Alves A., Adam R., Majno P., et al. Hepatic resection for metastatic renal tumors: is it worthwhile?. Ann Surg Oncol 6 (2003) 705-710
39. Hahn T.L., Jacobson L., Einhorn L.H., et al. Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol 7 (1999) 640-644
40. Goulet Jr. R.J., Hardacre J.M., Einhorn L.H., et al. Hepatic resection for disseminated germ cell carcinoma. Ann Surg 3 (1990) 290-293
41. Rivoire M., Elias D., De Cian F., et al. Multimodality treatment of patients with liver metastases from germ cell tumors: the role of surgery. Cancer 3 (2001) 578-587
42. Copson E., McKendrick J., Hennessey N., et al. Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy. BJU Int 4 (2004) 552-558
43. Yoon S.S., Jarnagin W.R., Fong Y., et al. Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol Oncol 2 (2003) 383-388
44. Merideth M.A., Cliby W.A., Keeney G.L., et al. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol 1 (2003) 16-21
45. Rivoire M., Kodjikian L., Baldo S., et al. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol 6 (2005) 422-428
46. Pawlik T.M., Zorzi D., Abdalla E.K., et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 5 (2006) 712-720
47. Wood B.J., Abraham J., Hvizda J.L., et al. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer 3 (2003) 554-560
48. Abdalla E.K., and Pisters P.W. Metastasectomy for limited metastases from soft tissue sarcoma. Curr Treat Options Oncol 6 (2002) 497-505
49. Chen H., Pruitt A., Nicol T.L., et al. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg 2 (1998) 151-155
50. Lang H., Nussbaum K.T., Kaudel P., et al. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 4 (2000) 500-505
51. DeMatteo R.P., Shah A., Fong Y., et al. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 4 (2001) 540-547
52. Pawlik T.M., Vauthey J.N., Abdalla E.K., et al. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 6 (2006) 537-543 [discussion: 543-4]
53. Jaques D.P., Coit D.G., Casper E.S., et al. Hepatic metastases from soft-tissue sarcoma. Ann Surg 4 (1995) 392-397
54. Bechtold R.E., Chen M.Y., Stanton C.A., et al. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec. Abdom Imaging 6 (2003) 808-814
55. Goh B.K., Chow P.K., Chuah K.L., et al. Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate. Eur J Surg Oncol 9 (2006) 961-963
56. Pawlik TM, Bauer TW, Reddy SK, et al. Hepatic resection for metastatic squamous cell carcinoma to the liver: a multi-center analysis. Ann Surg Oncol 2007, in press.
57. Ercolani G., Grazi G.L., Ravaioli M., et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 6 (2005) 459-466